26th EURORDIS Round Table of Companies Workshop, 21 February 2018

The development of rare diseases therapies requires the right regulatory, economic and political ecosystem to ensure that investments are made in areas where research would not otherwise be carried out. This workshop will try to take a balanced look at the role of incentives in therapies development, address shortcomings of the current system and consider what else the rare disease community can do to fulfil important unmet medical needs.

For more information click here.